NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE749.300 (0 %)
PREV CLOSE ( ) 749.30
OPEN PRICE ( ) 730.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4538
TODAY'S LOW / HIGH ( )730.15 755.05
52 WK LOW / HIGH ( )556.05 802.6
NSE749.800 (0 %)
PREV CLOSE( ) 749.80
OPEN PRICE ( ) 749.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 749.80 (25)
VOLUME 18717
TODAY'S LOW / HIGH( ) 743.05 756.00
52 WK LOW / HIGH ( )563.9 804
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 09-09 1936
Management Info
S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director
Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044- 24994465 / 24669000 / 18004254545

Email customercare@amrutanjan.com

Website www.amrutanjan.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
 Listing : BSE, NSE, Chennai
NEWS
08May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that the exchange has received the d..
07May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit174.51398.34
Gross Profit 237.08 536.45
Operating Profit 253.38589.34
Net Sales 1169.943796.36
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 6350.00 (2.04%)
M.Cap (Rs. in Cr)7984.49
Torrent Pharma (BSE)
 2757.80 (2.00%)
M.Cap (Rs. in Cr)91505.49
JB Chem & Pharma (BSE)
 1868.75 (2.00%)
M.Cap (Rs. in Cr)28435.24
Mankind Pharma (BSE)
 2122.25 (1.44%)
M.Cap (Rs. in Cr)83816.88
Glaxosmithkline Phar (BSE)
 2050.00 (1.29%)
M.Cap (Rs. in Cr)34285.24
MORE
Shareholding Pattern
PROMOTERS 50.59%
NON-INSTITUTION 40.74%
MUTUAL FUNDS/UTI 6.79%
FI/BANKS/INSURANCE 0.09%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal

Notices/Communique Links

BSE | NSE | MCX | CDSL
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.